849 related articles for article (PubMed ID: 31878941)
1. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
2. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
[TBL] [Abstract][Full Text] [Related]
3. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT.
You S; Han X; Xu Y; Sui L; Song K; Yao Q
Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
[TBL] [Abstract][Full Text] [Related]
4. IMB-6G, a novel N-substituted sophoridinic acid derivative, induces endoplasmic reticulum stress-mediated apoptosis via activation of IRE1α and PERK signaling.
Zhang N; Bi C; Liu L; Dou Y; Tang S; Pang W; Deng H; Song D
Oncotarget; 2016 Apr; 7(17):23860-73. PubMed ID: 27009865
[TBL] [Abstract][Full Text] [Related]
5. IRE1α-TRAF2-ASK1 pathway is involved in CSTMP-induced apoptosis and ER stress in human non-small cell lung cancer A549 cells.
Zhang J; Liang Y; Lin Y; Liu Y; YouYou ; Yin W
Biomed Pharmacother; 2016 Aug; 82():281-9. PubMed ID: 27470364
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1α, JNK and AP-1 pathway.
Shah A; Vaidya NK; Bhat HK; Kumar A
Sci Rep; 2016 Jan; 6():18929. PubMed ID: 26740125
[TBL] [Abstract][Full Text] [Related]
7. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
[TBL] [Abstract][Full Text] [Related]
8. Low expression level of HMBOX1 in high-grade serous ovarian cancer accelerates cell proliferation by inhibiting cell apoptosis.
Yu YL; Diao NN; Li YZ; Meng XH; Jiao WL; Feng JB; Liu ZP; Lu N
Biochem Biophys Res Commun; 2018 Jun; 501(2):380-386. PubMed ID: 29709478
[TBL] [Abstract][Full Text] [Related]
9. An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles.
Joshi N; Liu D; Dickson KA; Marsh DJ; Ford CE; Stenzel MH
J Mater Chem B; 2021 Nov; 9(44):9123-9135. PubMed ID: 34676865
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.
Merlot AM; Shafie NH; Yu Y; Richardson V; Jansson PJ; Sahni S; Lane DJR; Kovacevic Z; Kalinowski DS; Richardson DR
Biochem Pharmacol; 2016 Jun; 109():27-47. PubMed ID: 27059255
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
12. Active mixture of serum-circulating small molecules selectively inhibits proliferation and triggers apoptosis in cancer cells via induction of ER stress.
Scheffer D; Kulcsár G; Nagyéri G; Kiss-Merki M; Rékási Z; Maloy M; Czömpöly T
Cell Signal; 2020 Jan; 65():109426. PubMed ID: 31669205
[TBL] [Abstract][Full Text] [Related]
13. IRE1α dissociates with BiP and inhibits ER stress-mediated apoptosis in cartilage development.
Han X; Zhou J; Zhang P; Song F; Jiang R; Li M; Xia F; Guo FJ
Cell Signal; 2013 Nov; 25(11):2136-46. PubMed ID: 23816533
[TBL] [Abstract][Full Text] [Related]
14. β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway.
Liu Y; Jiang ZY; Zhou YL; Qiu HH; Wang G; Luo Y; Liu JB; Liu XW; Bu WQ; Song J; Cui L; Jia XB; Feng L
Biomed Pharmacother; 2017 Sep; 93():490-497. PubMed ID: 28672279
[TBL] [Abstract][Full Text] [Related]
15. Periplogenin Activates ROS-ER Stress Pathway to Trigger Apoptosis via BIP-eIF2α- CHOP and IRE1α-ASK1-JNK Signaling Routes.
Yang Y; Liu Y; Zhang Y; Ji W; Wang L; Lee SC
Anticancer Agents Med Chem; 2021; 21(1):61-70. PubMed ID: 32640963
[TBL] [Abstract][Full Text] [Related]
16. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y
J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms of IRE1α-ASK1 Pathway Reactions to Unfolded Protein Response in DRN Neurons of Post-Traumatic Stress Disorder Rats.
Kong F; Han F; Xu Y; Shi Y
J Mol Neurosci; 2017 Apr; 61(4):531-541. PubMed ID: 28210980
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumors.
Chiu TL; Su CC
Mol Med Rep; 2017 May; 15(5):3259-3263. PubMed ID: 28339041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
